Ignite Creation Date:
2024-05-05 @ 11:19 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004857
Status:
COMPLETED
Last Update Posted:
2016-07-06
First Post:
2000-03-07
Brief Title:
Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia
Sponsor:
Organization:
Alliance for Clinical Trials in Oncology